P. Zück

504 total citations
22 papers, 366 citations indexed

About

P. Zück is a scholar working on Pulmonary and Respiratory Medicine, Epidemiology and Infectious Diseases. According to data from OpenAlex, P. Zück has authored 22 papers receiving a total of 366 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Pulmonary and Respiratory Medicine, 12 papers in Epidemiology and 3 papers in Infectious Diseases. Recurrent topics in P. Zück's work include Pneumonia and Respiratory Infections (12 papers), Respiratory and Cough-Related Research (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). P. Zück is often cited by papers focused on Pneumonia and Respiratory Infections (12 papers), Respiratory and Cough-Related Research (10 papers) and Chronic Obstructive Pulmonary Disease (COPD) Research (4 papers). P. Zück collaborates with scholars based in France, United Kingdom and Canada. P. Zück's co-authors include Dirk Schürmann, R. Finch, Owen Collins, José Luís Izquierdo Alonso, P. Nikolaides, R Kubin, Raanan Raz, Gert Hoeffken, Herman Bobbaers and Christian Brambilla and has published in prestigious journals such as Antimicrobial Agents and Chemotherapy, Journal of Antimicrobial Chemotherapy and European Journal of Clinical Microbiology & Infectious Diseases.

In The Last Decade

P. Zück

20 papers receiving 341 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
P. Zück France	9	253	124	122	54	52	22	366
Anna Ochoa de Echagüen Spain	5	287 1.1×	187 1.5×	81 0.7×	42 0.8×	63 1.2×	8	459
R Kubin Germany	13	475 1.9×	228 1.8×	292 2.4×	121 2.2×	72 1.4×	13	694
C. Dustin Waters United States	11	182 0.7×	218 1.8×	158 1.3×	121 2.2×	36 0.7×	22	467
Juan-José Granizo Spain	12	207 0.8×	64 0.5×	44 0.4×	34 0.6×	109 2.1×	21	324
Deborah Church United States	8	501 2.0×	119 1.0×	172 1.4×	142 2.6×	29 0.6×	8	661
Emmanuel Novy France	9	142 0.6×	45 0.4×	109 0.9×	24 0.4×	73 1.4×	33	377
Evdoxia Tsigou Greece	7	159 0.6×	78 0.6×	53 0.4×	115 2.1×	30 0.6×	12	415
Shurjeel H Choudhri Canada	8	176 0.7×	71 0.6×	84 0.7×	20 0.4×	96 1.8×	12	321
Elisa García Spain	9	653 2.6×	120 1.0×	76 0.6×	35 0.6×	99 1.9×	14	834
Jennifer E Girotto United States	12	143 0.6×	65 0.5×	123 1.0×	72 1.3×	83 1.6×	35	372

Countries citing papers authored by P. Zück

Since Specialization

Citations

This map shows the geographic impact of P. Zück's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by P. Zück with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites P. Zück more than expected).

Fields of papers citing papers by P. Zück

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by P. Zück. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by P. Zück. The network helps show where P. Zück may publish in the future.

Co-authorship network of co-authors of P. Zück

This figure shows the co-authorship network connecting the top 25 collaborators of P. Zück. A scholar is included among the top collaborators of P. Zück based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with P. Zück. P. Zück is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Doco‐Lecompte, Thanh, Philippe Scheid, P. Zück, et al.. (2009). Revue de pertinence des fluoroquinolones en Lorraine : résultats de la première évaluation. Médecine et Maladies Infectieuses. 40(2). 106–111. 8 indexed citations

Léophonte, P, P. Zück, & C. Perronne. (2008). Profil et prise en charge de patients venant consulter pour une exacerbation de bronchopneumopathie chronique obstructive non sévère (enquête Pragma). Médecine et Maladies Infectieuses. 38(4). 200–207.

Léophonte, P, et al.. (2008). Utilisation de la clarithromycine à libération modifiée en traitement court des exacerbations aiguës d’une BPCO peu grave en pratique médicale courante. Médecine et Maladies Infectieuses. 38(9). 471–476. 1 indexed citations

Perronne, Christian, H. Drugeon, P. Zück, et al.. (2005). Efficacité et tolérance de la clarithromycine, forme à libération modifiée en traitement court de cinq jours dans les exacerbations aiguës de bronchite chronique, comparativement à la télithromycine. Médecine et Maladies Infectieuses. 35(10). 507–515. 4 indexed citations

Portier, H., Christian Brambilla, M Garré, et al.. (2005). Moxifloxacin monotherapy compared to amoxicillin-clavulanate plus roxithromycin for nonsevere community-acquired pneumonia in adults with risk factors. European Journal of Clinical Microbiology & Infectious Diseases. 24(6). 367–376. 38 indexed citations

Cuvelier, A., Jean‐François Muir, D. Benhamou, et al.. (2002). Dry powder ipratropium bromide is as safe and effective as metered-dose inhaler formulation: a cumulative dose-response study in chronic obstructive pulmonary disease patients.. PubMed. 47(2). 159–66. 9 indexed citations

Zück, P., et al.. (1999). BACTERIOLOGICAL ERADICATION OF STREPTOCOCCUS PNEUMONIAE FROM PATIENTS WITH ACUTE EXACERBATIONS OF CHRONIC BRONCHITIS: CEFUROXIME AXETIL VERSUS CEFIXIME. International Journal of Clinical Practice. 53(6). 437–443. 4 indexed citations

Zück, P., et al.. (1999). Randomized, double-blind study of short-course (5 day) grepafloxacin versus 10 day clarithromycin in patients with acute bacterial exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 44(4). 515–523. 33 indexed citations

Dellamonica, P., J. Gaillat, & P. Zück. (1998). Analyse des prescriptions dans les infectionsbroncho-pulmonaires communautaires de l'adulte, évaluation des quantités médicalement justifiées de céphalosporines injectables. Médecine et Maladies Infectieuses. 28(8-9). 618–627. 1 indexed citations

10.

Zück, P., et al.. (1997). [Antibiotic therapy in exacerbations of chronic bronchitis].. PubMed. 26(31). 1492–4.

11.

Zück, P., et al.. (1997). Céfixime versus amoxicilline-acide clavulanique dans le traitement des surinfections de bronchopathies chroniques chez des patients à risque. Médecine et Maladies Infectieuses. 27(5). 603–610. 1 indexed citations

12.

Piquet, J., P. Zück, Pierre‐Antoine Dugué, et al.. (1996). Equally efficacious asthma management with budesonide 800 micrograms administered by Turbuhaler or with beclomethasone dipropionate > or = 1500 micrograms given through a pressurized metered-dose inhaler with spacer. The French Budesonide Trial Group.. PubMed. 13(1). 38–50. 7 indexed citations

13.

Carbon, C, et al.. (1995). A double-blind randomized trial comparing the efficacy and safety of a 5-day course of cefotiam hexetil with that of a 10-day course of penicillin V in adult patients with pharyngitis caused by group A β-haemolytic streptococci. Journal of Antimicrobial Chemotherapy. 35(6). 843–854. 32 indexed citations

14.

Pfitzenmeyer, Pierre, Matthias Meier, P. Zück, et al.. (1994). Piroxicam induced pulmonary infiltrates and eosinophilia.. PubMed. 21(8). 1573–7. 14 indexed citations

15.

Germaud, P., et al.. (1993). Monothérapie par amoxicilline/acide clavulanique (AM-AC) en traitement de première intention dans les abcès pulmonaires communautaires. A propos de 57 cas.. Revue de Pneumologie Clinique. 49(3). 3 indexed citations

16.

Germaud, P., J.Y. Poirier, Jean Guérin, et al.. (1993). [Monotherapy using amoxicillin/clavulanic acid as treatment of first choice in community-acquired lung abscess. Apropos of 57 cases].. PubMed. 49(3). 137–41. 10 indexed citations

17.

Periti, P, et al.. (1990). Efficacy and tolerance of cefpodoxime proxetil compared with co-amoxiclav in the treatment of exacerbations of chronic bronchitis. Journal of Antimicrobial Chemotherapy. 26(suppl E). 63–69. 32 indexed citations

18.

Zück, P., et al.. (1990). Efficacy and tolerance of cefpodoxime proxetil compared with ceftriaxone in vulnerable patients with bronchopneumonia. Journal of Antimicrobial Chemotherapy. 26(suppl E). 71–77. 39 indexed citations

19.

Martinet, Y., et al.. (1980). ["Plastic lung". Broncho-pulmonary pathology related to plastics (author's transl)].. PubMed. 36(2). 135–46. 1 indexed citations

20.

Zück, P., et al.. (1978). Place actuelle et intérêt de la biopsie pulmonaire transbronchique perfibroscopique. Acta Endoscopica. 8(4). 301–311. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact